Posted On: 03/02/2014 2:00:54 AM
Post# of 105
APRI Recent News
Encana Delivers on Its Targets in a Year of Change, Well Positioned for 2014 Marketwire Canada - Thu Feb 13, 5:00AM CST
Apricus Shares Marginally Down on Vitaros Deal - Analyst Blog Zacks Investment Research - Wed Feb 12, 2:44PM CST
RECORDATI : OBTAINS VITAROS(R) LICENSE FROM APRICUS BIOSCIENCES GlobeNewswire - Mon Feb 10, 6:06AM CST
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream - Vitaros(R) in Spain, Russia, Turkey and Other Global Territories Thomson Reuters ONE - Mon Feb 10, 6:02AM CST
Raynauds Disease - Pipeline Review, H2 2013 Research Report M2 - Mon Feb 10, 2:22AM CST
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference GlobeNewswire - Tue Feb 04, 6:00AM CST
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Belgium Thomson Reuters ONE - Thu Jan 23, 9:34AM CST
Encana Delivers on Its Targets in a Year of Change, Well Positioned for 2014 Marketwire Canada - Thu Feb 13, 5:00AM CST
Apricus Shares Marginally Down on Vitaros Deal - Analyst Blog Zacks Investment Research - Wed Feb 12, 2:44PM CST
RECORDATI : OBTAINS VITAROS(R) LICENSE FROM APRICUS BIOSCIENCES GlobeNewswire - Mon Feb 10, 6:06AM CST
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream - Vitaros(R) in Spain, Russia, Turkey and Other Global Territories Thomson Reuters ONE - Mon Feb 10, 6:02AM CST
Raynauds Disease - Pipeline Review, H2 2013 Research Report M2 - Mon Feb 10, 2:22AM CST
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference GlobeNewswire - Tue Feb 04, 6:00AM CST
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Belgium Thomson Reuters ONE - Thu Jan 23, 9:34AM CST
(0)
(0)
